(b)(4) clinical study.It was reported that during a peripheral treatment procedure, watermelon seeding was noted.In mar 2013, rutherford assessment was category 3.The patient was treated as an outpatient.The target lesion was classified as a tasc b lesion located in the distal left superficial femoral artery (sfa) with 80% stenosis and was 100mm long with a reference vessel diameter of 6mm.The target lesion was treated with pre-dilation and placement of a 7x119x130mm innova stent, with 0% residual stenosis following post-dilation.In (b)(6) 2014, the patient reported left ankle pain/wound and was instructed to present to clinic.3 days later, the patient presented for unscheduled visit with complaint of left ankle wound.The patient was diagnosed with non healing osteomyelitis.Ultrasound revealed significant in-stent restenosis in the left sfa.The patient was hospitalized for treatment.While treating the in-stent restenosis with a 6x80mm sterling balloon, there was a watermelon seeding noted in the proximal portion, which was treated with a 6x2mm cutting balloon.The event was considered to be resolved without residual effects and the patient was discharged.
|
(b)(4).Device evaluated by mfr: it is indicated that the device will not be returned for evaluation; therefore a failure analysis of the complaint device could not be completed.A review of the batch history, historical trending, and similar complaint trending review for the product family will be conducted.If there is any further information from that review, a supplemental medwatch will be filed.(b)(4).
|